Rat Study Links Disc and Bone Degeneration to Chronic Low Back Pain Through Neural Sensitization | Research

The takeaway

Intervertebral disc and subchondral bone degeneration correlate with persistent low back pain in rats, mediated by neuronal sensitization including CGRP upregulation in dorsal root ganglia.

42-day pain correlation
Progressive disc/bone degeneration linked to persistent LBP via CGRP-mediated neural sensitization

What the researchers found

Disc and subchondral bone degeneration correlated with persistent LBP in rats, with neuronal sensitization including CGRP upregulation as a mediating mechanism.

Why it matters

Low back pain is the leading cause of disability worldwide. Understanding how structural degeneration drives pain through neuropeptide sensitization could identify new treatment targets.

How the study worked

Rat model with intradiscal MIA injection (2 mg); pain behavior assessment over 42 days; structural analysis; neuronal sensitization markers including CGRP.

What this study cannot tell us

Chemical-induced degeneration model may not fully represent natural aging or injury; rat pain behavior may not translate directly to human pain experience; 42-day timeframe is relatively short.

How to read the evidence

Controlled animal study with behavioral and molecular analysis — provides mechanistic evidence for the degeneration-pain relationship.

When this study was published

Published in 2026, advancing understanding of neuropeptide-mediated low back pain.

The bigger picture

This connects structural pathology to pain experience through neuropeptide signaling — explaining why some people with disc degeneration have severe pain while others with similar structural changes do not.

Questions still open

Could CGRP-targeting drugs (like those used for migraine) also treat degenerative low back pain?
What determines whether disc degeneration triggers neuronal sensitization versus remaining asymptomatic?

Common questions

How does disc degeneration cause pain?

When discs and surrounding bone break down, they release chemicals that sensitize nearby nerve endings. This study found that pain neuropeptides like CGRP increase in the nerve roots, amplifying pain signals from the damaged spine.

Could migraine drugs help back pain?

This study found CGRP — the same neuropeptide targeted by migraine drugs — is upregulated in back pain. CGRP-blocking drugs might someday be tested for chronic low back pain, though this hasn't been clinically studied yet.

Read the original research

Pathological Degeneration of Disc and Bone Is Associated With Chronic Low Back Pain in a Rat Model With Intradiscal Monosodium Iodoacetate.

Journal of cellular physiology, 241(1), e70140

View on PubMed ↗Publisher’s paper ↗

Citation

Cho, Yun-Ho; Choi, Cham; Kwon, Minji; Kwon, Jinju; Ok, Hogwang; Ryu, Dawon; Yang, Kyung-Sook; Kim, Junesun; Park, Eui Ho. (2026). Pathological Degeneration of Disc and Bone Is Associated With Chronic Low Back Pain in a Rat Model With Intradiscal Monosodium Iodoacetate.. Journal of cellular physiology, 241(1), e70140. https://doi.org/10.1002/jcp.70140